Drug Interaction Report

Oliceridine and Butorphanol Nasal Spray: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Oliceridine

Olinvyk
+

Butorphanol Nasal Spray

Stadol® NS
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 57 documented Oliceridine interactions, 57 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased risk of serotonin syndrome, an increased risk of hypotension, profound sedation, respiratory depression and reduced analgesic effect of oliceridine

Interaction Deep Dive

Avoid concomitant use of oliceridine (an opioid analgesic) with serotonergic CNS depressants and mixed opioid agonist/antagonist or a partial agonist opioid analgesic may increase the risk of hypotension, respiratory depression, profound sedation, coma, and death due to additive pharmacological effects and may reduce the analgesic effect of oliceridine, may precipitate withdrawal symptoms. Reserve concomitant prescription of these drugs for use in patients for whom alternative treatment options are inadequate. If the decision is made to prescribe CNS depressant concomitantly with an opioid analgesic, prescribe the lowest effective dosages and minimum durations of concomitant use. In patients already receiving an opioid analgesic, prescribe a lower initial dose of CNS depressant than indicated in the absence of an opioid, and titrate based on clinical response. If an opioid analgesic is initiated in a patient already taking other CNS depressant, prescribe a lower initial dose of the opioid analgesic, and titrate based on clinical response. Additionally, concomitant use with serotonergic agents may cause serotonin syndrome. Monitor patients closely for signs and symptoms of respiratory depression, sedation, serotonin syndrome and discontinue therapy if suspected1.

Why it happens (mechanism)

Additive serotonergic effects; additive CNS depression; opioid receptor antagonism

Literature reports

2 reports — tap to read

a) Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioid analgesics alone. Because of similar pharmacological properties, it is reasonable to expect similar risk with the concomitant use of other CNS depressant drugs with opioid analgesics 1.

b) In the post marketing experience, cases of serotonin syndrome, a potentially life-threatening condition, have been reported during concomitant use of opioids with serotonergic drugs 1.

Common questions

Can I take Oliceridine and Butorphanol Nasal Spray together?

Increased risk of serotonin syndrome, an increased risk of hypotension, profound sedation, respiratory depression and reduced analgesic effect of oliceridine Always confirm with your pharmacist or prescriber before making any change.

How serious is the Oliceridine and Butorphanol Nasal Spray interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Oliceridine or Butorphanol Nasal Spray need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: OLINVYK® intravenous injection, oliceridine intravenous injection. Trevena Inc (per FDA), Chesterbrook, PA, 2026. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.